Incidence of precancerous cervical lesions decreasing among young women
the ONA take:
According to a new study published in the journal Cancer, researchers have found that the incidence of high-grade cervical lesions in young women has significantly decreased, but the declines were likely due to reduced screening.
Cervical intraepithelial neoplasia grade 2, 3, and adenocarcinoma in situ (CIN2+) lesions can be monitored as early indicators of the effect of human papillomavirus (HPV) vaccines.
For the study, researchers identified over 9,000 cases of CIN2+ among patients aged 18 to 39 years in California, Connecticut, New York, and Oregon.
Researchers found that from 2008 to 2012, the rates of CIN2+ significantly decreased among women aged 18 to 20 years in all four states and among 21- to 29-year-old women in Connecticut and New York.
Researchers found that screening rates also declined during that time period, suggesting that the decline in these cervical lesions is most likely due to fewer screenings, but could potentially be an effect of vaccination as well.
Incidence of high-grade cervical lesions in young women has significantly decreased, but the declines were likely due to reduced screening.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|